Notice of Final Results

RNS Number : 1905U
Accrol Group Holdings PLC
11 July 2018
 

11 July 2018

Accrol Group Holdings plc

("Accrol" or the "Group")

AIM: ACRL

 

Notice of Final Results

 

Accrol, the leading independent tissue converter in the UK, will announce its Final Results for the year ended 30 April 2018 on Wednesday, 26 September 2018, which will include a full update on the progress of the Group's turnaround.

 

As previously announced, the Board continues to expect that the Group's underlying EBITDA for the year ended 30 April 2018 will be in line with market expectations.

 

Enquiries:

Accrol Group Holdings plc

Tel: +44 (0) 1254 278 844

Dan Wright, Executive Chairman

 

Gareth Jenkins, Chief Executive Officer

 

Steve Townsley, Chief Financial Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker)

 

Dan Bate / Andrew Jones                                                                  

Tel: +44 (0) 161 831 1512

Dominic King / John Goold                                                                     

Tel: +44 (0) 203 829 5000

 

 

Belvedere Communications Limited                                          

Tel: +44 (0) 203 567 0510

Catriona Valentine (cvalentine@belvederepr.com)

 

Llewellyn Angus (langus@belvederepr.com)

 

 

Notes to Editors

 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. 

 

Accrol operates from three sites:

 

·      A manufacturing, storage and distribution facility in Blackburn;

·      A facial tissue plant, also in Blackburn; and

·      A manufacturing, storage and distribution facility in Leyland.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORURSARWVABAAR
UK 100

Latest directors dealings